These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929 [TBL] [Abstract][Full Text] [Related]
5. Improving cancer immunotherapy by targeting tumor-induced immune suppression. Stewart TJ; Smyth MJ Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424 [TBL] [Abstract][Full Text] [Related]
12. Reverse immunoediting: When immunity is edited by antigen. Merlo A; Dalla Santa S; Dolcetti R; Zanovello P; Rosato A Immunol Lett; 2016 Jul; 175():16-20. PubMed ID: 27131431 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies. Seliger B HLA; 2016 Nov; 88(5):213-220. PubMed ID: 27659281 [TBL] [Abstract][Full Text] [Related]
15. Strategies of antigen-specific T-cell-based immunotherapy for cancer. Liu SH; Zhang M; Zhang WG Cancer Biother Radiopharm; 2005 Oct; 20(5):491-501. PubMed ID: 16248765 [TBL] [Abstract][Full Text] [Related]
16. Stochastic modeling of tumor progression and immune evasion. George JT; Levine H J Theor Biol; 2018 Dec; 458():148-155. PubMed ID: 30218648 [TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of tumor escape from immunologic response]. Costello RT; Gastaut JA; Olive D Rev Med Interne; 1999 Jul; 20(7):579-88. PubMed ID: 10434348 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy. Maccalli C; Parmiani G; Ferrone S Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848 [TBL] [Abstract][Full Text] [Related]
19. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Barsoum IB; Smallwood CA; Siemens DR; Graham CH Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068 [TBL] [Abstract][Full Text] [Related]
20. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Knutson KL; Disis ML Cancer Immunol Immunother; 2005 Aug; 54(8):721-8. PubMed ID: 16010587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]